| 发明名称 |
STABILIZATION OF THE ANTI-CD20 ANTIBODY RITUXIMAB |
| 摘要 |
<p>The invention provides isolated stabilized anti-CD20 antibodies and methods of their manufacture and use in diagnosis and treatment animal diseases including human lymphoma, leukemia, and autoimmunity.</p> |
| 申请公布号 |
EP2804952(A2) |
申请公布日期 |
2014.11.26 |
| 申请号 |
EP20120865606 |
申请日期 |
2012.01.19 |
| 申请人 |
THERAPEUTIC PROTEINS INTERNATIONAL, LLC |
发明人 |
WILTON, ROSEMARIE |
| 分类号 |
C12P21/08;A61K39/00;C07K16/00;C07K16/28 |
主分类号 |
C12P21/08 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
